The export of basic pharmaceutical products and pharmaceutical preparations from India to Indonesia experienced fluctuations from 2013 to 2023. In 2023, the exports stood at $141.0 million, showing a year-on-year increase of 4.39% from 2022. The compound annual growth rate (CAGR) over the past five years was 3.58%, reflecting moderate growth.

Projected forecasts indicate consistent growth through to 2028, with exports reaching approximately $169.59 million, corresponding to a five-year CAGR of 2.79% and a total growth rate of 14.73%.

Key future trends to watch for include:

Increased demand for pharmaceutical products driven by Indonesia's growing population and healthcare needs.
Potential policy changes in Indonesia affecting import regulations and tariffs.
Technological advancements in drug manufacturing enhancing the quality and cost-efficiency of exports.